Showing results (1271-1280 of 3,474) with videos related to

Sort By:
Pageof 348
Diabetes Research and Clinical Practice|May 1, 2007
Analysis of waist circumference in Japanese subjects with type 2 diabetes mellitus: lack of propriety to define the current criteria of metabolic syndromeYukiko Kanda, Masafumi Matsuda, Sumiko Hamamoto, et al.
The Journal of Hospital Infection|March 8, 2005
Residual formaldehyde on plastic materials and medical equipment following low-temperature steam and formaldehyde sterilizationK Kanemitsu, H Kunishima, T Saga, et al.
Journal of the National Cancer Institute|June 1, 1979
A microsomal butyrylesterase appearing in rat livers during development, regeneration, and carcinogenesis, and after phenobarbital treatmentA Kaneko, N Chisaka, K Enomoto, et al.
The Pediatric Infectious Disease Journal|March 16, 2010
THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005Kumi Ueno-Yamamoto, Keiko Tanaka-Taya, Hiroshi Satoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharideK Yagawa, M Kaku, Y Ichinose, et al.
No Shinkei Geka. Neurological Surgery|February 1, 1992
[Emergency manual aspiration for severe hypertensive cerebellar hemorrhage]H Nakashima, M Shigemori, T Kikuchi, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 22, 2005
Expression of RCAS1 in female genital organsYoshiaki Kawano, Tsunehisa Kaku, Kenzo Sonoda, et al.
The Journal of Toxicological Sciences|February 1, 1990
Protective effects of adrenoceptor-blocking agents on myocardial injury induced by epinephrine in miceT Kubota, N Yamazaki, J Sudo, et al.
Phytopathology|October 24, 2008
Involvement of Phosphoglucose Isomerase in Pathogenicity of Xanthomonas oryzae pv. oryzaeSeiji Tsuge, Hirokazu Ochiai, Yasuhiro Inoue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 16, 2011
An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancerAlan Sandler, Charles Graham, Maria Baggstrom, et al.
Pageof 348